1
|
Gahide G, Banine A, Cossette M, Budimir M, Chen L, Lefebvre J, Phaneuf SC, Haddad I, Vendrell JF, Beland M, Despatis MA, Maghsoudloo K. Reporting Peripheral Artery Disease in Claudicants: Lessons Learned From the TASC-Ability Study. J Endovasc Ther 2022; 30:259-268. [PMID: 35236151 DOI: 10.1177/15266028221081093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND The Trans-Atlantic Inter-Society Consensus Document (TASC II) aims to comprehensively describe the case scenarios of aortoiliac and femoropopliteal lesions to suggest an endovascular or a surgical approach. Over time, it has become a guide for describing the gravity of arterial lesions. PURPOSE To assess the revised TASC II system for classifying arterial lesions in a large database of patients presenting with claudication. MATERIALS AND METHODS This study was a retrospective review of the arteriograms of patients with intermittent claudication. Aortoiliac and femoropopliteal lesions were classified according to the TASC II. When no consensus was reached, the lesion was rated as unTASCable. RESULTS In total, 1454 patients were included (male: 62.1%, 66.8±9.3 years). There were 39% aortoiliac lesions (n=960/2462) and 61% femoropopliteal lesions (n=1502/2462); 33.6% of the patients (n=489/1454) were associated with aortoiliac and femoropopliteal lesions. In addition, 20% of the lesions (n=493/2462) were unTASCable, and 26.7% of the patients (n=388/1454) had at least 1 unTASCable lesion. There were 4 categories of unTASCable lesions: (1) association with a common femoral artery lesion in 53.1% (n=262/493); (2) iliac artery lesions in 23.1% (n=114/493); (3) femoropopliteal lesions whose lengths did not fit into any category in 16.6% (n=82/493); and (4) association with an aortic lesion in 7.1% (n=35/493). The interobserver agreement was 0.97 for anatomically describing the infrarenal arterial tree and 0.85 for TASCing, with the lesions lowering to 0.69 for aortoiliac lesions. CONCLUSION Using the revised TASC II case scenario, 26.7% of the patients had at least 1 unTASCable lesion. Reporting peripheral artery disease using a comprehensive anatomical description of the infrarenal arterial tree showed better interobserver reproducibility.
Collapse
Affiliation(s)
- Gérald Gahide
- Service d'Angioradiologie, Département d'Imagerie Médicale, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.,Centre de Recherche du CHUS, Etienne Le Bel, Université de Sherbrooke, Sherbrooke, QC, Canada
| | - Amine Banine
- Université de Sherbrooke, Sherbrooke, QC, Canada
| | | | | | - Lois Chen
- Université de Sherbrooke, Sherbrooke, QC, Canada
| | | | - Samuel C Phaneuf
- Service d'Angioradiologie, Département d'Imagerie Médicale, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
| | - Iskandar Haddad
- Service d'Angioradiologie, Département d'Imagerie Médicale, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
| | - Jean-Francois Vendrell
- Service d'Angioradiologie, Département d'Imagerie Médicale, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
| | - Mathieu Beland
- Département de Radiologie, Centre Hospitalier Universitaire de Québec, Quebec City, Canada
| | - Marc-Antoine Despatis
- Centre de Recherche du CHUS, Etienne Le Bel, Université de Sherbrooke, Sherbrooke, QC, Canada.,Service de Chirurgie Vasculaire, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
| | | |
Collapse
|
3
|
Banafsche R, Jerkku T, Tsilimparis N. Commentary: What ILIACS Can Tell Us - Future Perspectives of Endovascular AIOD Treatment. J Endovasc Ther 2019; 26:633-636. [PMID: 31466494 DOI: 10.1177/1526602819871867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Ramin Banafsche
- Department of Vascular Surgery, Ludwig-Maximilians-University Hospital Munich, Germany
| | - Thomas Jerkku
- Department of Vascular Surgery, Ludwig-Maximilians-University Hospital Munich, Germany
| | - Nikolaos Tsilimparis
- Department of Vascular Surgery, Ludwig-Maximilians-University Hospital Munich, Germany
| |
Collapse
|
4
|
Creager MA, Hiatt WR, Hirsch AT, Olin JW, Jaff MR, Cooke JP, Rooke T, Beckman JA, Froehlich JB. The Society for Vascular Medicine: the first quarter century. Vasc Med 2015; 20:60-8. [PMID: 25722420 DOI: 10.1177/1358863x14566042] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The Society for Vascular Medicine was founded in 1989. During the subsequent 25 years, the Society has grown to approximately 500 members and has achieved international recognition while making important contributions to vascular disease education, clinical vascular medicine and biology research, and patient care. In celebration of the Society's 25th anniversary, its past and current presidents reflect on the Society's history, challenges, and achievements, and emphasize the vital role of the SVM in the discipline of vascular medicine.
Collapse
Affiliation(s)
- Mark A Creager
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | | | | | | | - Michael R Jaff
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - John P Cooke
- Houston Methodist Research Institute, Houston, TX, USA
| | | | - Joshua A Beckman
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | | |
Collapse
|